Synthesis, Cytotoxicity, Antimicrobial and Docking Simulation of Novel Pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c] pyrimidine Derivatives
-
Published:2019-04-23
Issue:8
Volume:19
Page:657-670
-
ISSN:1389-5575
-
Container-title:Mini-Reviews in Medicinal Chemistry
-
language:en
-
Short-container-title:MRMC
Author:
Hassaneen Hamdi M.1, Saleh Fatma M.1, Abdallah Tayseer A.1, Mohamed Magda F.2, Mohamed Yasmin Sh.3, Awad Enas M.4, Abdelhamid Ismail A.1
Affiliation:
1. Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt 2. Chemistry Department (Biochemistry Branch), Faculty of Science, Cairo University, Giza, Egypt 3. National Organization for Drug Control and Research, Dokki, Giza, Egypt 4. Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Cairo, Egypt
Abstract
Background:Isobutyrohydrazonoyl bromide 1 was used as a precursor for the synthesis of 4-imino-3-isopropyl-1-(4-nitrophenyl)-1,4-dihydro-5H-pyrazolo[3,4-d]pyrimidin-5-amine 4, which was converted into hydrazino derivative 5 by heating with hydrazine hydrate at reflux. Hydrazino, as well as imino-amino derivatives, underwent condensation and cyclization reactions to give pyrazolo[ 3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c]pyrimidine derivatives, respectively.Method:Antimicrobial studies are performed using two-gram positive bacteria and two-gram negative bacteria.Results:Data revealed that compound 9a is the most promising antibacterial agent with high efficiency (low MIC value (48 μg/ml)). The cytotoxic assay was investigated for in vitro antitumor screening against Caucasian breast adenocarcinoma MCF7, hepatocellular carcinoma HepG2 and colon carcinoma HCT-116 cell lines.Conclusion:The results are compared with doxorubicin standard anticancer drugs as well as normal cell lines like MCF10 and MCF12. Molecular docking was carried out for the highest potent compound 8c with the binding site of dihydrofolate reductase enzyme DHFR PDB:ID (1DLS).
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Reference62 articles.
1. Hassaneen HM, Shetta A, Shawali AS. J Heterocycl Chem, Hydrazidoyl halides in synthesis of Δ2-1,3,4-Selenadiazolin-5-ones., 1980, 17, 1185-1187, 2. Shawali AS, Hassaneen HM, Shetta AF, Osman A, Abdel-Galil F. Heterocycles, regioselectivity of reactions of 2-Furoyl-N-Aryl nitrile imine with some dipolarophiles., 1982, 19, 57-66, 3. Awad EM, Elwan NM, Hassaneen HM, Linden A, Heimgartner H. Helv Chim Acta, New routes to fused isoquinolines., 2002, 85, 320-332, 4. Elwan NM, Awad EM, Hassaneen HM, Linden A, Heimgartner H. Helv Chim Acta, Synthesis of 1,2,4-Triazolo[4,3-a]Pyrimidine derivatives by cyclocondensation of a 2-Thioxopyrimidin-4(3H)-One with hydrazonoyl halides., 2003, 86, 739-749, 5. Hassaneen HM, Hassaneen HME, Mohammed YS, Pagni RM. Zeitschrift für Naturforsch B, Synthesis, reactions and antibacterial activity of 3-Acetyl[1,2,4]Triazolo[3,4-a]Isoquinoline derivatives using chitosan as heterogeneous catalyst under microwave irradiation., 2011, 66, 299-310,
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Substituted Pyrimidine-Sulfonamide Derivatives: Computational, Synthesis, Characterization, Anti-bacterial, MTT and Molecular Docking Assessment;BIOINTERFACE RES APP;2023 2. The Synthesis, Antimicrobial Activity, and Molecular Docking of New 1, 2, 4-Triazole, 1, 2, 4-Triazepine, Quinoline, and Pyrimidine Scaffolds Condensed to Naturally Occurring Furochromones;Pharmaceuticals;2022-10-07 3. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA;Bioorganic Chemistry;2021-11 4. 4-(3-Phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)thieno[3,2-d]pyrimidine;Molbank;2020-05-17 5. Synthesis of 3-methylthio-1-phenyl-pyrazolo[3,4-d][1,2,4]triazolo[1,5-a]pyrimidin-4-one derivatives via tandem aza-Wittig reaction;Synthetic Communications;2020-01-13
|
|